Globeflex Capital L P Invests $1.64 Million in Addus HomeCare Corporation $ADUS

Globeflex Capital L P purchased a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS) in the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 16,275 shares of the company’s stock, valued at approximately $1,635,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. BlackRock Inc. purchased a new position in shares of Addus HomeCare during the 2nd quarter valued at $344,153,000. Capital Research Global Investors grew its stake in shares of Addus HomeCare by 22.3% in the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock valued at $157,837,000 after buying an additional 268,192 shares in the last quarter. Vanguard Group Inc. lifted its stake in Addus HomeCare by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock valued at $140,531,000 after acquiring an additional 10,501 shares during the last quarter. Wasatch Advisors LP raised its holdings in shares of Addus HomeCare by 0.8% during the 3rd quarter. Wasatch Advisors LP now owns 936,243 shares of the company’s stock valued at $110,467,000 after purchasing an additional 7,089 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Addus HomeCare by 11.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company’s stock valued at $69,689,000 after purchasing an additional 78,415 shares during the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $120.82 on Tuesday. The company’s fifty day moving average is $109.99 and its two-hundred day moving average is $102.58. Addus HomeCare Corporation has a 52-week low of $87.95 and a 52-week high of $124.43. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69. The firm has a market capitalization of $2.26 billion, a price-to-earnings ratio of 21.20, a P/E/G ratio of 1.62 and a beta of 0.87.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, August 3rd. The company reported $1.73 EPS for the quarter, beating analysts’ consensus estimates of $1.70 by $0.03. The business had revenue of $377.41 million during the quarter, compared to analyst estimates of $376.24 million. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.Addus HomeCare’s revenue was up 8.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.49 earnings per share. Equities research analysts forecast that Addus HomeCare Corporation will post 6.29 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have commented on ADUS. Citizens Jmp reissued a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a research report on Monday, May 18th. Royal Bank Of Canada boosted their price target on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Barclays upped their price target on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research note on Wednesday, July 8th. Citigroup reissued a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Finally, Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Addus HomeCare has an average rating of “Moderate Buy” and an average target price of $130.88.

Insider Activity

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the business’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the transaction, the insider directly owned 44,371 shares in the company, valued at $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is owned by company insiders.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.